These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 36289579)

  • 21. CD44 isoforms are heterogeneously expressed in breast cancer and correlate with tumor subtypes and cancer stem cell markers.
    Olsson E; Honeth G; Bendahl PO; Saal LH; Gruvberger-Saal S; Ringnér M; Vallon-Christersson J; Jönsson G; Holm K; Lövgren K; Fernö M; Grabau D; Borg A; Hegardt C
    BMC Cancer; 2011 Sep; 11():418. PubMed ID: 21957977
    [TBL] [Abstract][Full Text] [Related]  

  • 22. PDGF suppresses the sulfation of CD44v and potentiates CD44v-mediated binding of colon carcinoma cells to fibrin under flow.
    Alves CS; Konstantopoulos K
    PLoS One; 2012; 7(10):e41472. PubMed ID: 23056168
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CD44 variant-dependent redox status regulation in liver fluke-associated cholangiocarcinoma: A target for cholangiocarcinoma treatment.
    Thanee M; Loilome W; Techasen A; Sugihara E; Okazaki S; Abe S; Ueda S; Masuko T; Namwat N; Khuntikeo N; Titapun A; Pairojkul C; Saya H; Yongvanit P
    Cancer Sci; 2016 Jul; 107(7):991-1000. PubMed ID: 27176078
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of CD44 splice variants in human skin and epidermal tumours.
    Seiter S; Tilgen W; Herrmann K; Schadendorf D; Patzelt E; Möller P; Zöller M
    Virchows Arch; 1996 Jun; 428(3):141-9. PubMed ID: 8688968
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CD44 splice isoform switching determines breast cancer stem cell state.
    Zhang H; Brown RL; Wei Y; Zhao P; Liu S; Liu X; Deng Y; Hu X; Zhang J; Gao XD; Kang Y; Mercurio AM; Goel HL; Cheng C
    Genes Dev; 2019 Feb; 33(3-4):166-179. PubMed ID: 30692202
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interplay between Podoplanin, CD44s and CD44v in Squamous Carcinoma Cells.
    Montero-Montero L; Renart J; Ramírez A; Ramos C; Shamhood M; Jarcovsky R; Quintanilla M; Martín-Villar E
    Cells; 2020 Sep; 9(10):. PubMed ID: 33003440
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CD44 variant-dependent regulation of redox balance in EGFR mutation-positive non-small cell lung cancer: A target for treatment.
    Kawano Y; Iwama E; Tsuchihashi K; Shibahara D; Harada T; Tanaka K; Nagano O; Saya H; Nakanishi Y; Okamoto I
    Lung Cancer; 2017 Nov; 113():72-78. PubMed ID: 29110853
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Correlation of CD44 expression with proliferative activity of normal human breast epithelial cells in culture.
    Cooper NL; Bardy P; Bacani J; Kuusk U; Dougherty GJ; Eaves CJ; Emerman JT
    Breast Cancer Res Treat; 1998 Jul; 50(2):143-53. PubMed ID: 9822219
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detection of CD44 splice variants in formalin-fixed, paraffin-embedded specimens of human skin cancer.
    Dietrich A; Tanczos E; Vanscheidt W; Schöpf E; Simon JC
    J Cutan Pathol; 1997 Jan; 24(1):37-42. PubMed ID: 9027631
    [TBL] [Abstract][Full Text] [Related]  

  • 30. RP215 single chain fragment variable and single domain recombinant antibodies induce cell cycle arrest at G0/G1 phase in breast cancer.
    Yu F; Wang Y; Xiao Y; He Y; Luo C; Duan D; Li C; Xu S; Xiang T
    Mol Immunol; 2014 May; 59(1):100-9. PubMed ID: 24534066
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A link between ras and metastatic behavior of tumor cells: ras induces CD44 promoter activity and leads to low-level expression of metastasis-specific variants of CD44 in CREF cells.
    Hofmann M; Rudy W; Günthert U; Zimmer SG; Zawadzki V; Zöller M; Lichtner RB; Herrlich P; Ponta H
    Cancer Res; 1993 Apr; 53(7):1516-21. PubMed ID: 8453616
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cellular distribution of CD44 gene transcripts in colorectal carcinomas and in normal colonic mucosa.
    Gorham H; Sugino T; Woodman AC; Tarin D
    J Clin Pathol; 1996 Jun; 49(6):482-8. PubMed ID: 8763263
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of Hepatitis C Virus Core and E2 antigenic recombinant proteins and their use for development of diagnostic assays.
    Ali A; Nisar M; Idrees M; Rafique S; Iqbal M
    Int J Infect Dis; 2015 May; 34():84-9. PubMed ID: 25796431
    [TBL] [Abstract][Full Text] [Related]  

  • 34. SLUG/SNAI2 and tumor necrosis factor generate breast cells with CD44+/CD24- phenotype.
    Bhat-Nakshatri P; Appaiah H; Ballas C; Pick-Franke P; Goulet R; Badve S; Srour EF; Nakshatri H
    BMC Cancer; 2010 Aug; 10():411. PubMed ID: 20691079
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Molecular cloning of recombinant fibronectin EDA and EDB fusion protein].
    Xue AM; Wang H; Ye R
    Fa Yi Xue Za Zhi; 2002 Aug; 18(3):140-3. PubMed ID: 12608290
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential expression of CD44 variants among meningioma subtypes.
    Suzuki SO; Iwaki T; Kitamoto T; Mizoguchi M; Fukui M; Tateishi J
    Clin Mol Pathol; 1996 Jun; 49(3):M140-6. PubMed ID: 16696062
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of CD44 variant expression in oral, head and neck squamous cell carcinomas using a triple approach and its clinical significance.
    Athanassiou-Papaefthymiou M; Shkeir O; Kim D; Divi V; Matossian M; Owen JH; Czerwinski MJ; Papagerakis P; McHugh J; Bradford CR; Carey TE; Wolf GT; Prince ME; Papagerakis S
    Int J Immunopathol Pharmacol; 2014; 27(3):337-49. PubMed ID: 25280025
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of CD44 splice variants during lymphocyte activation and tumor progression.
    Griffioen AW; Horst E; Heider KH; Wielenga VJ; Adolf GR; Herrlich P; Pals ST
    Cell Adhes Commun; 1994 Jul; 2(3):195-200. PubMed ID: 7530151
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nuclear beta-catenin and CD44 upregulation characterize invasive cell populations in non-aggressive MCF-7 breast cancer cells.
    Uchino M; Kojima H; Wada K; Imada M; Onoda F; Satofuka H; Utsugi T; Murakami Y
    BMC Cancer; 2010 Aug; 10():414. PubMed ID: 20696077
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Expression, purification and immunoreactivity characterization of extracellular antigenic domains of NMDAR1 protein].
    Bao D; Li W; Shi L; Li Q
    Sheng Wu Gong Cheng Xue Bao; 2017 Dec; 33(12):1979-1988. PubMed ID: 29271175
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.